Abstract
Nonsevere Clostridium difficile infection (CDI) and severe CDI, which carries a higher risk than nonsevere CDI for treatment failure and CDI recurrence, are difficult to distinguish at the time of diagnosis. To investigate the prognostic value of 3 markers of severe CDI suggested by recent guidelines (fever, leukocytosis, and renal failure), we used the database of 2 randomized controlled trials, which contained information for 1105 patients with CDI. Leukocytosis (risk ratio [RR], 2.29; 95% confidence interval [CI], 1.63-3.21) and renal failure (RR, 2.52; 95% CI, 1.82-3.50) were associated with treatment failure. Fever, although associated with treatment failure (RR, 2.45; 95% CI, 1.07-5.61), was rare. Renal failure was the only significant predictor of recurrence (RR, 1.45; 95% CI, 1.05-2.02). Different timing of measurements of leukocyte count and serum creatinine level around the CDI diagnosis led to a different severity classification in many cases. In conclusion, both leukocytosis and renal failure are useful predictors, although timing of measurement is important.
| Original language | English |
|---|---|
| Pages (from-to) | S149-53 |
| Journal | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
| Volume | 55 |
| Issue number | Suppl 2 |
| DOIs | |
| Publication status | Published - Aug 2012 |
| Externally published | Yes |
Keywords
- Aminoglycosides/therapeutic use
- Anti-Bacterial Agents/therapeutic use
- Clostridioides difficile/pathogenicity
- Clostridium Infections/complications
- Confidence Intervals
- Creatine/analysis
- Fever/complications
- Fidaxomicin
- Humans
- Leukocyte Count
- Leukocytosis/etiology
- Odds Ratio
- Prognosis
- ROC Curve
- Randomized Controlled Trials as Topic
- Recurrence
- Renal Insufficiency/etiology
- Severity of Illness Index
- Time Factors
- Treatment Failure
- Vancomycin/therapeutic use